Intravenous recombinant tissue plasminogen activator (t-PA) administration is the standard reperfusion therapy for acute ischemic stroke within 4.5 h of onset; t-PA induces thrombus dissolution by activating plasminogen into plasmin (12). The gene discussed is PLG; the disease is ischemic stroke.